Karius
Founded Year
2014Stage
Series B | AliveTotal Raised
$240MValuation
$0000Last Raised
$165M | 3 yrs agoAbout Karius
Karius is a life sciences company focused on conquering infectious diseases through the use of sequencing to analyze microbial cell-free DNA. The company's genomics platform delivers insight into the microbial landscape, providing clinicians with a comprehensive test capable of identifying more than a thousand pathogens directly from blood and helping industry accelerate drug development.
Karius's Product Videos
Compete with Karius?
Ensure that your company and products are accurately represented on our platform.
Karius's Products & Differentiators
The Karius Test
Karius is delivering a commercially available liquid biopsy for infectious diseases test that can diagnose deep seated and bloodstream infections rapidly, non-invasively, and quantitatively. The company can measure microbial cell-free DNA (mcfDNA) in blood plasma for >1,000 pathogens (bacteria, DNA viruses, fungi, and parasites). The test detects mcfDNA in extremely low abundance compared to human DNA, with high specificity for each pathogen in the report. The test overcomes significant challenges of high human background and cross-reactivity to provide an accurate diagnosis by a day after specimen receipt, compared with up to weeks for some standard-of-care (SOC) methods.
Research containing Karius
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Karius in 10 CB Insights research briefs, most recently on Jan 31, 2022.
Dec 1, 2020
Can Applying AI To Genomics Improve Healthcare?Expert Collections containing Karius
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Karius is included in 8 Expert Collections, including Conference Exhibitors.
Conference Exhibitors
5,501 items
HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare
Omics
1,542 items
Artificial Intelligence
10,623 items
This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
2,623 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health 150
150 items
The winners of the second annual CB Insights Digital Health 150.
Karius Patents
Karius has filed 13 patents.
The 3 most popular patent topics include:
- Molecular biology
- Biotechnology
- DNA
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
5/13/2020 | 11/23/2021 | Molecular biology, DNA, Biotechnology, Genetics, DNA sequencing | Grant |
Application Date | 5/13/2020 |
---|---|
Grant Date | 11/23/2021 |
Title | |
Related Topics | Molecular biology, DNA, Biotechnology, Genetics, DNA sequencing |
Status | Grant |
Latest Karius News
Apr 29, 2023
Newcastle United's 2023 out of contract players as expiry dates edge closer Matt Ritchie is among six Newcastle players who are out of contract in the summer. × Invalid emailSomething went wrong, please try again later. Sign Up We use your sign-up to provide content in the ways you've consented to and improve our understanding of you. This means that we may include adverts from us and third parties based on our knowledge of you. We also may change the frequency you receive our emails from us in order to keep you up to date and give you the best relevant information possible. As always you can unsubscribe at any time. More info × Newcastle United have six players out of contract in June, as Eddie Howe continues his rebuild at St James' Park ahead of the summer transfer window. The Newcastle boss has assembled a strong squad during his first three transfer windows at the helm, and this summer is expected to be another big window, especially if Newcastle secure Champions League qualification. Jonjo Shelvey was the headline name on Newcastle's 2023 out of contract contingent prior to his move to Nottingham Forest in January. But there are six names who are yet to decide on their futures as their respective contracts run into their final two months. ChronicleLive have rounded up which Newcastle players are out of contract in the summer of 2023... Matt Ritchie Ritchie has spent the last seven seasons at St James' Park but his stay on Tyneside appears to be coming to after falling down the pecking order under Eddie Howe. The 33-year-old had a spell on the sidelines just prior to the World Cup but has been available for selection since the Premier League resumed. However, he has amassed just 212 minutes across all competitions, and only 32 minutes in the Premier League this season. Football Insider claimed in February that Ritchie has received interest from clubs in the Championship and League One, as well as in his native Scotland. Loris Karius Karius joined Newcastle's goalkeeping contingent back in September last year following an injury to Karl Darlow. The former Liverpool stopper was signed purely to provide back-up, although he was presented with his debut in Newcastle's 2-0 Carabao Cup final defeat against Manchester United in February. It could prove to be his first and last appearance for the Magpies unless both Nick Pope and Martin Dubravka are both unavailable (strangers things have happened) in any of the final seven games. According to a report from fcinternews.it in March, Karius has emerged as a target for Inter Milan, with the Serie A giants viewing him as a 'low-cost deputy' to Andre Onana. Matty Longstaff Matty Longstaff, the younger brother of fellow Newcastle midfielder Sean, marked his Premier League debut with a stunning strike in a 1-0 win over Manchester United in October 2019. However, the 23-year-old has been unable to build on his stunning start to life at St James' Park, and has not appeared for the first team since January 2021. Longstaff has been plagued by a number of injury problems, and was sent out on loan to Aberdeen and Mansfield Town last season. He once again returned to League Two with Colchester United for the current campaign, but was ruled out for the remainder of the season after suffering a serious knee injury on Boxing Day. Paul Dummett Dummett has spent his entire career at Newcastle bar loan spells at Gateshead and St Mirren respectively between 2012 and 2013. The Welshman was a crucial figure as Newcastle lifted the Championship title, and has provided steady back-up for much of his 11 seasons at St James' Park. But Dummett faced a spell on the sidelines either side of the World Cup break, and is still yet to make a single Premier League appearance this term. His only appearance in any competition this season came in a 2-1 win over Tranmere Rovers in the EFL Cup second round in August 2022. Mark Gillespie Gillespie penned a three-year deal with his hometown club Newcastle in July 2020 after spending eight years in the academy between 2000 and 2008. He has never made a single Premier League appearance for the Magpies, although he did feature three times during their EFL Cup campaign in 2020/21. Ciaran Clark Clark joined Sheffield United on a season-long loan back in the summer in a move that virtually ended his Newcastle career considering he had run into the final year of his contract. The defender has amassed 127 appearances for the Magpies since arriving from Aston Villa in 2016. He has been reduced to just 11 outings at Sheffield United this term due to injury, but has just achieved automatic promotion with the Blades. READ NEXT
Karius Frequently Asked Questions (FAQ)
When was Karius founded?
Karius was founded in 2014.
Where is Karius's headquarters?
Karius's headquarters is located at 975 Island Drive, Redwood City.
What is Karius's latest funding round?
Karius's latest funding round is Series B.
How much did Karius raise?
Karius raised a total of $240M.
Who are the investors of Karius?
Investors of Karius include Lightspeed Venture Partners, Khosla Ventures, SoftBank , HBM Healthcare Investments, General Catalyst and 7 more.
Who are Karius's competitors?
Competitors of Karius include IDbyDNA and 2 more.
What products does Karius offer?
Karius's products include The Karius Test.
Who are Karius's customers?
Customers of Karius include Baylor College of Medicine, Lucile Packard Children's Hospital, Duke Clinical Research Institute, Indiana University and St. Jude Children's Research Hospital.
Compare Karius to Competitors
Sequentia Biotech is a bioinformatics company that transforms omics data into knowledge. The company offers bioinformatics cloud softwares, custom softwares and bioinformatics consulting services for healthcare, pharma, agriculture, industry and the environment.
BGI Group is a life science group that operates multiple research labs and entities in the field of genomics, healthcare, precision medicine, and more. The subsidiaries include BGI Genomics, BGI Agriculture, BGI Healthcare, BGI Life Science Research Institute, and others.
Aperiomics identifies bacteria, viruses, fungi, and parasites through Deep Shotgun Metagenomic Sequencing, using its database of microbes. The company helps doctors and their patients identify the causes of infections that other tests cannot identify, thus streamlining the path to a positive clinical outcome.
Hugo Biotechnology specializes in microbial sequencing and big data analysis of the microbial genome.
IDbyDNA is a search engine to identify pathogens in samples. It develops technologies to enable universal microorganism detection by next-generation sequencing (NGS). It was founded in 2014 and is based in Salt Lake City, Utah. In June 2022, IDbyDNA was acquired by Illumina.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.